Sisodia Vibuthi, Ursinus Rosalie, Geurtsen Gert J, Wiggerts Yarit, Schuurman Peter Richard, Beudel Martijn, de Bie Rob M A, Swinnen Bart E K S
Department of Neurology, Amsterdam UMC, Amsterdam Neuroscience, University of Amsterdam, Amsterdam, The Netherlands.
Department of Medical Psychology, Amsterdam UMC, Amsterdam Neuroscience, University of Amsterdam, Amsterdam, The Netherlands.
Neuromodulation. 2025 Apr;28(3):484-491. doi: 10.1016/j.neurom.2024.07.011. Epub 2024 Sep 28.
This study aimed to assess the influence of preoperative cognition on postoperative motor and nonmotor outcomes in patients with Parkinson disease (PD) after deep brain stimulation (DBS).
A retrospective study was performed in subjects with PD with bilateral subthalamic DBS. Preoperative cognition was indexed by Parkinson's Disease-Cognitive Rating Scale (PD-CRS) and global neuropsychological evaluation (NPE) scores. The primary outcome was change from baseline to postoperative off-drug Movement Disorders Society Unified Parkinson Disease Rating Scale (MDS-UPDRS) part 3 score. Secondary outcomes included change from baseline to postoperative MDS-UPDRS part 1 subscores.
The study included 226 subjects; 176 patients (77.9%) had normal cognition (PD-NC); 48 (21.2%) had mild cognitive impairment (MCI), and two (0.9%) had PD dementia. Proportional change (-41.4% vs -52.2%, p = 0.013) in off-drug MDS-UPDRS part 3 score was smaller in PD-MCI than in PD-NC. PD-CRS (Pearson's r = 0.236, p < 0.001) and NPE (Pearson's r = 0.219, p < 0.001) scores displayed a positive correlation with proportional change in off-drug MDS-UPDRS part 3 score. Worse PD-CRS scores were related to larger improvements in MDS-UPDRS part 1.2 (hallucinations) (Pearson's r = 0.135, p = 0.045).
DBS induces a clinically meaningful motor improvement in patients with cognitive impairment and PD, but the improvement may be smaller than in patients who are not cognitively affected. Further research into the risk-benefit balance of DBS in people with PD and cognitive dysfunction is warranted.
本研究旨在评估帕金森病(PD)患者在接受脑深部电刺激(DBS)术前认知对术后运动和非运动结果的影响。
对接受双侧丘脑底核DBS的PD患者进行回顾性研究。术前认知通过帕金森病认知评定量表(PD-CRS)和整体神经心理学评估(NPE)得分进行评估。主要结局是从基线到术后未服药状态下运动障碍协会统一帕金森病评定量表(MDS-UPDRS)第3部分得分的变化。次要结局包括从基线到术后MDS-UPDRS第1部分各子得分的变化。
该研究纳入了226名受试者;176例患者(77.9%)认知正常(PD-NC);48例(21.2%)有轻度认知障碍(MCI),2例(0.9%)有PD痴呆。PD-MCI患者未服药状态下MDS-UPDRS第3部分得分的比例变化(-41.4%对-52.2%,p = 0.013)小于PD-NC患者。PD-CRS(Pearson相关系数r = 0.236,p < 0.001)和NPE(Pearson相关系数r = 0.219,p < 0.001)得分与未服药状态下MDS-UPDRS第3部分得分的比例变化呈正相关。较差的PD-CRS得分与MDS-UPDRS第1.2部分(幻觉)的更大改善相关(Pearson相关系数r = 0.135,p = 0.045)。
DBS可使认知障碍的PD患者在临床上获得有意义的运动改善,但改善程度可能小于未受认知影响的患者。有必要进一步研究DBS在PD和认知功能障碍患者中的风险效益平衡。